LEMAITRE VASCULAR, INC. Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months
LEMAITRE VASCULAR, INC. (LMAT) had Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months of $930.00 thousand as of 2013-12-31, per its 10-Q filed 2013-05-08.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Rolling Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths · last filed 2013-08-09
- 2013-12-31: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $930.00K.
- 2013-06-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $975.00K.
- 2012-12-31: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $1.05M; Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months as first filed $724.00K.
| Period end | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months as first filed |
|---|---|---|
| 2013-12-31 | $930.00K 10-Q · filed 2013-05-08 | |
| 2013-06-30 | $975.00K 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $1.05M 10-K · filed 2013-03-27 | $724.00K 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |